Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun 10;19(1):86.
doi: 10.1186/s12969-021-00570-w.

COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?

Affiliations
Comment

COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?

Nasim Movahedi et al. Pediatr Rheumatol Online J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no competing interests.

Comment on

  • Myositis as a manifestation of SARS-CoV-2.
    Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre AS, Thomas M, Herrou J, Riviere E, Mariette X. Beydon M, et al. Ann Rheum Dis. 2021 Mar;80(3):e42. doi: 10.1136/annrheumdis-2020-217573. Epub 2020 Apr 23. Ann Rheum Dis. 2021. PMID: 32327427 No abstract available.
  • COVID-19-associated myositis may be dermatomyositis.
    Tanboon J, Nishino I. Tanboon J, et al. Muscle Nerve. 2021 Jan;63(1):E9-E10. doi: 10.1002/mus.27105. Epub 2020 Nov 15. Muscle Nerve. 2021. PMID: 33095493 No abstract available.

References

    1. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020;79(5):667–668. doi: 10.1136/annrheumdis-2020-217424. - DOI - PMC - PubMed
    1. Gokhale Y, Patankar A, Holla U, Shilke M, Kalekar L, Karnik ND, Bidichandani K, Baveja S, Joshi A. Dermatomyositis during COVID-19 pandemic (a case series): is there a cause effect relationship? J Assoc Physicians India. 2020;68(11):20–24. - PubMed
    1. Manzano GS, Woods JK, Amato AA. Covid-19-associated myopathy caused by type I interferonopathy. N Engl J Med. 2020;383(24):2389–2390. doi: 10.1056/NEJMc2031085. - DOI - PMC - PubMed
    1. Tanboon J, Nishino I. COVID-19-associated myositis may be dermatomyositis. Muscle Nerve. 2021;63(1):E9–E10. doi: 10.1002/mus.27105. - DOI - PubMed
    1. Beydon M, Chevalier K, Al Tabaa O, et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis. 2021;80(3):e42. doi: 10.1136/annrheumdis-2020-217573. - DOI - PubMed